APUS
Price
$5.15
Change
+$0.23 (+4.67%)
Updated
Jul 31 closing price
Capitalization
7.77M
Intraday BUY SELL Signals
TRLV
Price
$8.65
Change
+$0.08 (+0.93%)
Updated
Jul 31 closing price
Capitalization
1.66B
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APUS vs TRLV

APUS vs TRLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APUS vs. TRLV commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APUS is a Hold and TRLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (APUS: $5.15 vs. TRLV: $8.65)
Brand notoriety: APUS and TRLV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APUS: 228% vs. TRLV: 54%
Market capitalization -- APUS: $7.77M vs. TRLV: $1.66B
APUS [@Pharmaceuticals: Generic] is valued at $7.77M. TRLV’s [@Pharmaceuticals: Generic] market capitalization is $1.66B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APUS’s FA Score shows that 1 FA rating(s) are green whileTRLV’s FA Score has 1 green FA rating(s).

  • APUS’s FA Score: 1 green, 4 red.
  • TRLV’s FA Score: 1 green, 4 red.
According to our system of comparison, TRLV is a better buy in the long-term than APUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APUS’s TA Score shows that 5 TA indicator(s) are bullish while TRLV’s TA Score has 2 bullish TA indicator(s).

  • APUS’s TA Score: 5 bullish, 3 bearish.
  • TRLV’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, APUS is a better buy in the short-term than TRLV.

Price Growth

APUS (@Pharmaceuticals: Generic) experienced а -8.85% price change this week, while TRLV (@Pharmaceuticals: Generic) price change was +3.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.61%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +19.02%.

Reported Earning Dates

TRLV is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRLV($1.66B) has a higher market cap than APUS($7.77M). TRLV YTD gains are higher at: -0.460 vs. APUS (-68.598).
APUSTRLVAPUS / TRLV
Capitalization7.77M1.66B0%
EBITDA-39.53MN/A-
Gain YTD-68.598-0.46014,903%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.64MN/A-
Total Debt9.53MN/A-
FUNDAMENTALS RATINGS
TRLV: Fundamental Ratings
TRLV
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APUSTRLV
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
APUS
Daily Signal:
Gain/Loss:
TRLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QTWO60.871.80
+3.05%
Q2 Holdings
MTD1416.3035.69
+2.59%
Mettler-Toledo International
MRDN11.270.12
+1.03%
Meridian Holdings Inc.
NXL0.34N/A
-1.23%
Nexalin Technology
SG6.45-0.10
-1.53%
Sweetgreen

APUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APUS has been loosely correlated with DERM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APUS jumps, then DERM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APUS
1D Price
Change %
APUS100%
+4.67%
DERM - APUS
49%
Loosely correlated
-1.24%
SNOA - APUS
41%
Loosely correlated
-2.65%
ACB - APUS
24%
Poorly correlated
-1.41%
TRLV - APUS
10%
Poorly correlated
+0.93%
YCBD - APUS
6%
Poorly correlated
+7.62%
More

TRLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRLV has been closely correlated with GLAS. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then GLAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRLV
1D Price
Change %
TRLV100%
+0.93%
GLAS - TRLV
75%
Closely correlated
-3.74%
CGC - TRLV
69%
Closely correlated
-0.08%
ACB - TRLV
65%
Loosely correlated
-1.41%
CRON - TRLV
61%
Loosely correlated
-2.08%
OGI - TRLV
54%
Loosely correlated
-2.96%
More